Prot #233AS303: A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-Label Extension to Evaluate BIIB067 Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

Project: Research project

Project Details

StatusActive
Effective start/end date8/12/218/12/24

Funding

  • DrugDev Inc. (Prot #233AS303 // Prot #233AS303)
  • Biogen MA Inc. (Prot #233AS303 // Prot #233AS303)